Dr. Daniel Cannone, D.O

NPI: 1750483962
Total Payments
$716,540
2024 Payments
$42,696
Companies
10
Transactions
1,070

Payment Breakdown by Category

Other$512,257 (71.5%)
Travel$122,480 (17.1%)
Consulting$63,460 (8.9%)
Food & Beverage$18,296 (2.6%)
Education$47.57 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $508,881 223 71.0%
Travel and Lodging $122,480 474 17.1%
Consulting Fee $63,460 24 8.9%
Food and Beverage $18,296 341 2.6%
Honoraria $3,376 1 0.5%
Education $47.57 7 0.0%

Top Paying Companies

Company Total Records Latest Year
ACADIA Pharmaceuticals Inc $553,585 832 $0 (2024)
Janssen Pharmaceuticals, Inc $141,885 184 $0 (2019)
Collegium Pharmaceutical, Inc. $13,522 35 $0 (2020)
Sun Pharmaceutical Industries Inc. $4,434 4 $0 (2019)
Sunovion Pharmaceuticals Inc. $1,525 9 $0 (2017)
Genentech, Inc. $1,215 1 $0 (2022)
Janssen Scientific Affairs, LLC $191.58 2 $0 (2018)
Actelion Pharmaceuticals US, Inc. $80.00 1 $0 (2019)
Amarin Pharma Inc. $65.62 1 $0 (2019)
Biogen, Inc. $36.91 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $42,696 88 ACADIA Pharmaceuticals Inc ($42,696)
2023 $85,036 182 ACADIA Pharmaceuticals Inc ($85,036)
2022 $73,122 133 ACADIA Pharmaceuticals Inc ($71,907)
2021 $64,275 98 ACADIA Pharmaceuticals Inc ($64,238)
2020 $38,931 45 ACADIA Pharmaceuticals Inc ($38,890)
2019 $103,185 148 ACADIA Pharmaceuticals Inc ($87,959)
2018 $64,864 84 ACADIA Pharmaceuticals Inc ($47,212)
2017 $244,431 292 ACADIA Pharmaceuticals Inc ($115,648)

All Payment Transactions

1,070 individual payment records from CMS Open Payments — Page 1 of 43

Date Company Product Nature Form Amount Type
12/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $29.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $25.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $20.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $16.08 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $16.08 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $13.07 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/02/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $10.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/27/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,000.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/18/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $564.61 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/14/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $197.15 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/14/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $12.41 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/08/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $250.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/01/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $291.97 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/01/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $282.98 General
Category: PARKINSONS DISEASE PSYCHOSIS
09/18/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/24/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Travel and Lodging In-kind items and services $750.10 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/22/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $120.61 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/16/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee Cash or cash equivalent $500.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/01/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $8.63 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/28/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $3.78 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/17/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,500.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/10/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $646.20 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/10/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $303.97 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/10/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $66.18 General
Category: PARKINSONS DISEASE PSYCHOSIS

About Dr. Daniel Cannone, D.O

Dr. Daniel Cannone, D.O is a Geriatric Medicine healthcare provider based in Wadsworth, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750483962.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Cannone, D.O has received a total of $716,540 in payments from pharmaceutical and medical device companies, with $42,696 received in 2024. These payments were reported across 1,070 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($508,881).

Practice Information

  • Specialty Geriatric Medicine
  • Location Wadsworth, OH
  • Active Since 09/01/2006
  • Last Updated 09/15/2021
  • Taxonomy Code 207QG0300X
  • Entity Type Individual
  • NPI Number 1750483962

Products in Payments

  • NUPLAZID (Drug) $552,805
  • XARELTO (Drug) $142,077
  • Xtampza ER (Drug) $13,279
  • DRIZALMA SPRINKLE (Drug) $4,434
  • BROVANA (Drug) $1,525
  • XTAMPZA (Drug) $207.53
  • Vascepa (Drug) $65.62
  • XTAMPZA ER (Drug) $34.79

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.